Direct coupling of the cell cycle and cell death machinery by E2F

Nature Cell Biology

Volumn 4, Issue 11, 2002, Pages 28-34

  Nahle, Zaher ^a,b   Polakoff, Julia ^a   Davuluri, Ramana V ^a,c   McCurrach, Mila E ^a   Jacobson, Matthew D ^b   Narita, Masashi ^a   Zhang, Michael Q ^a   Lazebnik, Yuri ^a   Bar Sagi, Dafna ^b   Lowe, Scott W ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; ENZYME PRECURSOR; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE S PHASE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOGENICITY; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN DEPLETION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ADENOVIRUS E1A PROTEINS; ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; CASPASES; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CPG ISLANDS; CYTOCHROMES C; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; FIBROBLASTS; HUMANS; LUCIFERASES; MICE; MODELS, BIOLOGICAL; MODELS, GENETIC; PROMOTER REGIONS (GENETICS); RETINOBLASTOMA PROTEIN; RNA; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE;

EID: 85006277004     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb868     Document Type: Article

References (36)

1. Evan, G. I. & Vousden, K. H. Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342-348 (2001).
2. Sherr, C. J. The INK4a/ARF network in tumour suppression. Nature Rev. Mol. Cell Biol. 2, 731-737 (2001).
3. Trimarchi, J. M. & Lees, J. A. Sibling rivalry in the E2F family. Nature Rev. Mol. Cell Biol. 3, 11-20 (2002).
4. Tolbert, D., Lu, X., Yin, C., Tantama, M. & Van Dyke, T. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumour suppression in vivo. Mol. Cell. Biol. 22, 370-377 (2002).
5. Russell, J. L. et al. ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol. Cell. Biol. 22, 1360-1368 (2002).
6. Tsai, K. Y. et al. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2, 293-304 (1998).
7. Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262 (1998).
8. Phillips, A. C., Ernst, M. K., Bates, S., Rice, N. R. & Vousden, K. H. E2F-1 potentiates cell death by blocking anti-apoptotic signalling pathways. Mol. Cell 4, 771-781 (1999).
9. Irwin, M. et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407, 645-648 (2000).
10. Stiewe, T. & Putzer, B. M. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nature Genet. 26, 464-469 (2000).
11. Bates, S. et al. p14ARF links the tumour suppressors RB and p53. Nature 395, 124-125 (1998).
12. Thornberry, N. A. & Lazebnik, Y. Caspases: enemies within. Science 281, 1312-1316 (1998).
13. Soengas, M. S. et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumour inhibition. Science 284, 156-159 (1999).
14. Fearnhead, H. O. et al. Oncogene-dependent apoptosis is mediated by caspase-9. Proc. Natl Acad. Sci. USA 95, 13664-13669 (1998).
15. de Stanchina, E. et al. E1A signalling to p53 involves the p19(ARF) tumour suppressor. Genes Dev. 12, 2434-2442 (1998).
16. Moroni, M. C. et al. Apaf-1 is a transcriptional target for E2F and p53. Nature Cell Biol. 3, 552-558 (2001).
17. Robles, A. I., Bemmels, N. A., Foraker, A. B. & Harris, C. C. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. Cancer Res. 61, 6660-6664 (2001).
18. Samuelson, A. V. & Lowe, S. W. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. Proc. Natl Acad. Sci. USA 94, 12094-12099 (1997).
19. Vigo, E. et al. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol. Cell. Biol. 19, 6379-6395 (1999).
20. Muller, H. et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation and apoptosis. Genes Dev. 15, 267-285 (2001).
21. Kel, A. E. et al. Computer-assisted identification of cell cycle-related genes: New targets for E2F transcription factors. J. Mol. Biol. 309, 99-120 (2001).
22. Takahashi, Y., Rayman, J. B. & Dynlacht, B. D. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev. 14, 804-816 (2000).
23. Hakem, R. et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94, 339-352 (1998).
24. Varfolomeev, E. E. et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267-276 (1998).
25. McCurrach, M. E., Connor, T. M., Knudson, C. M., Korsmeyer, S. J. & Lowe, S. W. bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl Acad. Sci. USA 94, 2345-2349 (1997).
26. Narita, M. et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl Acad. Sci. USA 95, 14681-14686 (1998).
27. Yang, X., Chang, H. Y. & Baltimore, D. Autoproteolytic activation of pro-caspases by oligomerization. Mol. Cell 1, 319-325 (1998).
28. Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S. & Dixit, V. M. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273, 2926-2930 (1998).
29. Wu, X. & Levine, A. J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl Acad. Sci. USA 91, 3602-3606 (1994).
30. Routes, J. M. et al. Adenovirus E1A oncogene expression in tumour cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL). J. Immunol. 165, 4522-4527 (2000).
31. Lin, A. W. & Lowe, S. W. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation. Proc. Natl Acad. Sci. USA 98, 5025-5030 (2001).
32. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997).
33. Schwarz, J. K. et al. Expression of the E2F1 transcription factor overcomes type β transforming growth factor-mediated growth suppression. Proc. Natl Acad. Sci. USA 92, 483-487 (1995).
34. Harlow, E., Franza, B. R. & Schley, C. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. J. Virol. 55, 533-546 (1985).
35. Joneson, T. & Bar-Sagi, D. Suppression of Ras-induced apoptosis by the Rac GTPase. Mol. Cell. Biol. 19, 5892-5901 (1999).
36. Clackson, T. et al. Transcriptional squelching re-examined. Nature Med. 2, 1028-1032 (1996).